A Multicenter, Randomized , Dose -Ranging, Double -Blind, Placebo -Controlled Study to Evaluate  
the Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe  
Glabellar Lines  
Study ID: [REMOVED]  
Protocol Document Dat e: 10Aug2018  